Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming
Aimee Merino, … , Jeffrey S. Miller, Frank Cichocki
Aimee Merino, … , Jeffrey S. Miller, Frank Cichocki
Published June 18, 2019
Citation Information: J Clin Invest. 2019;129(9):3770-3785. https://doi.org/10.1172/JCI125916.
View: Text | PDF
Research Article Immunology

Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming

  • Text
  • PDF
Abstract

A population of NK cells expressing the activating receptor NKG2C and the maturation marker CD57 expands in response to human CMV (HCMV) infection. CD3–CD56dimCD57+NKG2C+ NK cells are similar to CD8+ memory T cells with rapid and robust effector function upon restimulation, persistence, and epigenetic remodeling of the IFNG locus. Chronic antigen stimulation drives CD8+ memory T cell proliferation, while also inducing genome-wide epigenetic reprograming and dysfunction. We hypothesized that chronic stimulation could similarly induce epigenetic reprograming and dysfunction in NK cells. Here, we show that chronic stimulation of adaptive NK cells through NKG2C using plate-bound agonistic Abs in combination with IL-15 drove robust proliferation and activation of CD3–CD56dimCD57+NKG2C+ NK cells, while simultaneously inducing high expression of the checkpoint inhibitory receptors LAG-3 and PD-1. Marked induction of checkpoint inhibitory receptors was also observed on the surface of adaptive NK cells cocultured with HCMV-infected endothelial cells. Chronically stimulated adaptive NK cells were dysfunctional when challenged with tumor targets. These cells exhibited a pattern of epigenetic reprograming, with genome-wide alterations in DNA methylation. We believe our study has important implications for cancer immunotherapy and propose that exhausted NK cells could be targeted with inhibitory checkpoint receptor blockade.

Authors

Aimee Merino, Bin Zhang, Philip Dougherty, Xianghua Luo, Jinhua Wang, Bruce R. Blazar, Jeffrey S. Miller, Frank Cichocki

×

Figure 3

Chronic stimulation of adaptive NK cells through NKG2C leads to a CD45 isoform switch.

Options: View larger image (or click on image) Download as PowerPoint
Chronic stimulation of adaptive NK cells through NKG2C leads to a CD45 i...
CD3/CD19-depleted PBMCs from HCMV-seropositive donors were cultured for 7 days with 10 ng/ml IL-15 and IgG2b isotype Ab, anti-NKG2A/C Ab, or anti-NKG2C Ab. (A) Representative FACS plots and summary data of the percentages of CD45RA+RO– and CD45RA–CD45RO+ NK cells within the CD3–CD56dimNKG2C– and CD3–CD56dimNKG2C+ subsets prior to culturing (n = 5). (B) Representative FACS plots and summary data on the percentages and MFIs of CD45RA and CD45RO on CD3–CD56+NKG2C– NK cells and CD3–CD56+NKG2C+ NK cells after a 7-day culture (n = 7). Results are from 3 independent experiments. (C) Summary data for CD45RA+CD45RO– and CD45RA–CD45RO+ NK cell proliferation after culturing (n = 5), as measured by CellTrace dye dilution. Results are from 2 independent experiments. *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001, by paired t test. P values for multiple group comparisons (within the NKG2C– NK cell groups, within the NKG2C+ NK cell groups, and between the NKG2C– and NKG2C+ NK cell groups) were adjusted using the Hommel method.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts